The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Duncan Jason since 2020.
This trader's CIK number is 1741553.
At the time of last reporting, Duncan Jason was the Chief Legal Officer and GC of Albireo Pharma, Inc.. (stock ticker symbol ALBO).
Also see all insider trading activities at Albireo Pharma, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | ALBO | 0 | $0 | 1,166 | $51,167 | 0 | $0 |
2022 | ALBO | 0 | $0 | 3,656 | $92,659 | 0 | $0 |
2021 | ALBO | 0 | $0 | 19,073 | $685,799 | 16,600 | $406,183 |
2020 | ALBO | 0 | $0 | 4,719 | $199,976 | 3,500 | $84,140 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-01-23 | ALBO | Sale | 228 | 43.80 | 9,986 |
2023-01-19 | ALBO | Sale | 938 | 43.90 | 41,181 |
2022-10-24 | ALBO | Sale | 656 | 19.50 | 12,793 |
2022-07-25 | ALBO | Sale | 313 | 24.02 | 7,519 |
2022-07-22 | ALBO | Sale | 344 | 24.56 | 8,450 |
2022-04-25 | ALBO | Sale | 312 | 33.42 | 10,427 |
2022-04-22 | ALBO | Sale | 343 | 33.00 | 11,318 |
2022-01-24 | ALBO | Sale | 1,688 | 24.97 | 42,152 |
2021-10-22 | ALBO | Sale | 95 | 28.85 | 2,740 |
2021-10-25 | ALBO | Sale | 217 | 29.21 | 6,338 |
2021-07-23 | ALBO | Sale | 223 | 31.43 | 7,008 |
2021-07-22 | ALBO | Sale | 90 | 34.13 | 3,071 |
2021-06-24 | ALBO | Option Ex | 10,000 | 24.36 | 243,550 |
2021-06-25 | ALBO | Option Ex | 6,300 | 24.67 | 155,421 |
2021-06-24 | ALBO | Sale | 10,000 | 36.38 | 363,800 |
2021-06-25 | ALBO | Sale | 6,300 | 36.22 | 228,186 |
2021-04-22 | ALBO | Sale | 90 | 31.75 | 2,857 |
2021-04-23 | ALBO | Sale | 222 | 32.32 | 7,175 |
2021-04-01 | ALBO | Option Ex | 300 | 24.04 | 7,212 |
2021-04-01 | ALBO | Sale | 300 | 36.16 | 10,847 |
2021-03-31 | ALBO | Sale | 1,426 | 35.04 | 49,969 |
2021-01-22 | ALBO | Sale | 110 | 34.62 | 3,808 |
2020-10-22 | ALBO | Sale | 89 | 34.71 | 3,089 |
2020-09-08 | ALBO | Option Ex | 3,500 | 24.04 | 84,140 |
2020-09-08 | ALBO | Sale | 4,000 | 45.55 | 182,200 |
2020-07-22 | ALBO | Sale | 91 | 25.80 | 2,347 |
2020-04-22 | ALBO | Sale | 92 | 17.68 | 1,626 |
2020-01-22 | ALBO | Sale | 447 | 23.97 | 10,714 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Duncan Jason (Chief Legal Officer and GC of Albireo Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.